NeuroPace, Inc.

NASDAQ:NPCE

13.4 (USD) • At close April 15, 2024
Bedrijfsnaam NeuroPace, Inc.
Symbool NPCE
Munteenheid USD
Prijs 13.4
Beurswaarde 379,817,640
Dividendpercentage 0%
52-weken bereik 3.795 - 18.15
Industrie Medical Devices
Sector Healthcare
CEO Mr. Joel D. Becker
Website https://www.neuropace.com

An error occurred while fetching data.

Over NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians

Vergelijkbare Aandelen

Compugen Ltd. logo

Compugen Ltd.

CGEN

1.96 USD

Quipt Home Medical Corp. logo

Quipt Home Medical Corp.

QIPT

3.78 USD

Savara Inc. logo

Savara Inc.

SVRA

5.04 USD

Clene Inc. logo

Clene Inc.

CLNN

0.331 USD

Vor Biopharma Inc. logo

Vor Biopharma Inc.

VOR

1.8 USD

Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc.

FENC

10.33 USD

High Tide Inc. logo

High Tide Inc.

HITI

2.24 USD

Meihua International Medical Technologies Co., Ltd. logo

Meihua International Medical Technologies Co., Ltd.

MHUA

0.66 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)